ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,211, issued on Dec. 9, was assigned to TOHOKU UNIVERSITY (Sendai, Japan).
"Therapy for interstitial cystitis by pluripotent stem cells" was invented by Tokunori Yamamoto (Nagoya, Japan), Shinobu Shimizu (Nagoya, Japan), Akira Furuta (Tokyo), Mari Dezawa (Sendai, Japan) and Yasumasa Kuroda (Sendai, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The purpose of the present invention is to provide a novel medical application using pluripotent stem cells in regenerative medicine. The present invention provides a cell formulation and pharmaceutical composition that are for amelioration and therapy for frequent urination and bladder pain caused by the...